These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23433455)
1. Protein therapeutics targeted at the TNF superfamily. Ware CF Adv Pharmacol; 2013; 66():51-80. PubMed ID: 23433455 [TBL] [Abstract][Full Text] [Related]
2. Clinical targeting of the TNF and TNFR superfamilies. Croft M; Benedict CA; Ware CF Nat Rev Drug Discov; 2013 Feb; 12(2):147-68. PubMed ID: 23334208 [TBL] [Abstract][Full Text] [Related]
3. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. Dostert C; Grusdat M; Letellier E; Brenner D Physiol Rev; 2019 Jan; 99(1):115-160. PubMed ID: 30354964 [TBL] [Abstract][Full Text] [Related]
4. The role of TNF superfamily members in T-cell function and diseases. Croft M Nat Rev Immunol; 2009 Apr; 9(4):271-85. PubMed ID: 19319144 [TBL] [Abstract][Full Text] [Related]
6. The multiple faces of CCL13 in immunity and inflammation. Mendez-Enriquez E; García-Zepeda EA Inflammopharmacology; 2013 Dec; 21(6):397-406. PubMed ID: 23846739 [TBL] [Abstract][Full Text] [Related]
7. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436 [TBL] [Abstract][Full Text] [Related]
8. The TNF superfamily in 2009: new pathways, new indications, and new drugs. Tansey MG; Szymkowski DE Drug Discov Today; 2009 Dec; 14(23-24):1082-8. PubMed ID: 19837186 [TBL] [Abstract][Full Text] [Related]
9. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Xu WD; Zhao Y; Liu Y Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091 [TBL] [Abstract][Full Text] [Related]
10. Modulation of tumor necrosis factor by microbial pathogens. Rahman MM; McFadden G PLoS Pathog; 2006 Feb; 2(2):e4. PubMed ID: 16518473 [TBL] [Abstract][Full Text] [Related]
11. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Croft M; Siegel RM Nat Rev Rheumatol; 2017 Apr; 13(4):217-233. PubMed ID: 28275260 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms. Ali MY; Akter Z; Mei Z; Zheng M; Tania M; Khan MA Biomed Pharmacother; 2021 Feb; 134():111157. PubMed ID: 33370631 [TBL] [Abstract][Full Text] [Related]
16. The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses. Ward-Kavanagh LK; Lin WW; Šedý JR; Ware CF Immunity; 2016 May; 44(5):1005-19. PubMed ID: 27192566 [TBL] [Abstract][Full Text] [Related]
17. A New Venue of TNF Targeting. Steeland S; Libert C; Vandenbroucke RE Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751683 [TBL] [Abstract][Full Text] [Related]
18. TNF superfamily protein-protein interactions: feasibility of small- molecule modulation. Song Y; Buchwald P Curr Drug Targets; 2015; 16(4):393-408. PubMed ID: 25706111 [TBL] [Abstract][Full Text] [Related]
19. Structural insights of homotypic interaction domains in the ligand-receptor signal transduction of tumor necrosis factor (TNF). Park YH; Jeong MS; Jang SB BMB Rep; 2016 Mar; 49(3):159-66. PubMed ID: 26615973 [TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor superfamily members in ischaemic vascular diseases. Nash M; McGrath JP; Cartland SP; Patel S; Kavurma MM Cardiovasc Res; 2019 Mar; 115(4):713-720. PubMed ID: 30816914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]